Citi Upgrades BioAge Labs Stock on Promising Obesity Drug Potential
Citi analyst upgrades BioAge Labs to Buy with $10 price target, citing BGE-102 obesity drug as potentially game-changing treatment option.
NOTRELOAD AI
Vertiv Crushes Q3 Earnings: AI Infrastructure Boom Drives 60% Order Growth
Vertiv reports strong Q3 2025 results with EPS of $1.24 beating estimates. AI-driven demand fuels revenue growth and raised full-year guidance.
Texas Instruments Stock Falls on Weak Q4 Forecast Amid Trade Uncertainty
Texas Instruments shares drop 8% after forecasting Q4 revenue below expectations. Trade tensions with China and tariff concerns threaten chip demand recovery.
Mattel Misses Sales Target as Retailers Delay Toy Orders Amid Tariff Uncertainty
Mattel's Q3 earnings fell short as US retailers postponed orders due to tariff concerns. Stock dropped 6% after reporting $1.74B in sales versus $1.84B expected.
Netflix Q3 Earnings Hit by Brazil Tax Bill, But Outlook Remains Strong
Netflix's Q3 earnings fell short of Wall Street expectations due to a $619M Brazilian tax settlement, though the streaming giant maintains positive outlook with strong programming ahead.
Travis Kelce Teams Up with Activist Investor to Transform Six Flags
NFL star Travis Kelce joins hedge fund Jana Partners in a $200M investment push to revitalize Six Flags through better marketing, customer experience, and potential leadership changes.